会议专题

Protein Tyrosine Phosphatase SHP-1 Sensitizes EGFR/HER-2 Positive Breast Cancer Cells to Trastuzumab through Modulating Phosphorylation of EGFR and HER-2

Objective: Trastuzumab-resistance in HER-2 positive breast caner cells is closely related to both overexpression of EGFR.SHP-1 has been demonstrated to down-regulate tyrosine kinase activity including EGFR via its phosphatase function, but its effect on HER2 activity is still unknown.Here, we examined the hypothesis that SHP-1 enhances the anticancer efficacy of trastuzumab in EGFR/HER-2 positive breast cancer through combining dual inhibition of EGFR and HER-2.

吴依芬 罗荣城

南方医科大学中西医结合医院;东莞市人民医院肿瘤内科 南方医科大学中西医结合医院肿瘤中心

国内会议

第九届中国肿瘤内科大会、第四届中国肿瘤医师大会暨中国抗癌协会肿瘤临床化疗专业委员会2015年学术年会

北京

英文

688-689

2015-07-01(万方平台首次上网日期,不代表论文的发表时间)